Physician profile
Bryan D Smith
NPI 1548243199
$3,128.74
in general payments reported to CMS, 2019-2025
35 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $216 · 2021: $390 · 2022: $967 · 2023: $238 · 2024: $353 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $510.08 | 2019-2022 | |
| Janssen Biotech, INC. | $323.12 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $291.70 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $264.27 | 2020-2024 | Prolaris, Myrisk |
| Pfizer INC. | $226.17 | 2019-2022 | |
| Rochester Medical Corporation | $216.38 | 2020-2022 | |
| Abbvie INC. | $177.15 | 2019-2025 | Botox |
| Olympus America INC. | $132.51 | 2019-2025 | Soltive |
| Bayer Healthcare Pharmaceuticals INC. | $130.76 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $79.94 | 2022-2025 | Pylarify |
| Myovant Sciences INC. | $55.82 | 2021-2022 | |
| Allergan, INC. | $55.08 | 2019-2021 | |
| Amgen INC. | $52.24 | 2019-2021 | |
| Urovant Sciences INC | $52.10 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $48.42 | 2021-2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $44.12 | 2022-2025 | Barrigel |
| Intuitive Surgical, INC. | $42.58 | 2023 | Da Vinci Surgical System |
| Baxter Healthcare | $42.37 | 2019 | |
| Dendreon Pharmaceuticals LLC | $39.24 | 2019 | |
| Laborie Medical Technologies Corp. | $39.07 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $37.59 | 2024-2025 | |
| Dentsply Ih INC. | $29.91 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $29.89 | 2023 | Bard Urinary Drainage Bag |
| Bk Medical Holding Company INC. | $26.63 | 2020 | |
| Urogen Pharma, INC. | $22.18 | 2023 | Jelmyto |
| Clarus Therapeutics INC. | $19.79 | 2021 | |
| Endo Pharmaceuticals INC. | $18.97 | 2019 | |
| Janssen Scientific Affairs, LLC | $18.82 | 2019 | |
| Convatec INC. | $18.58 | 2021 | |
| Axonics, INC. | $18.23 | 2021 | |
| Boston Scientific Corporation | $17.74 | 2025 | Lithovue |
| Medtronic, INC. | $15.89 | 2025 | Interstim |
| Foundation Medicine, INC. | $14.88 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.70 | 2019 | |
| Travere Therapeutics, INC. | $3.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.